We next assessed alterations of EZH2 or other genes encoding core PRC2 components by targeted sequencing in breast cancer metastases previously analyzed by Affymetrix CytoScan arrays (Le Tourneau et al. 2014). Here, EZH2 is linked to breast cancer.